Fetcroja

Fetcroja is an intravenous antibiotic used to treat serious bacterial infections. It contains cefiderocol, a novel cephalosporin designed for resistant strains. Learn more about its uses and effects.

Fetcroja is primarily used for the treatment of complicated urinary tract infections and hospital-acquired pneumonia caused by resistant bacteria. It is often prescribed when other antibiotics have proven ineffective. The primary active ingredient, cefiderocol, targets specific bacterial enzymes to disrupt cell wall synthesis, making it effective against a broad range of bacterial infections.

Common effects of Fetcroja may include infusion site reactions, diarrhea, and elevated liver enzymes. Some patients may experience nausea or vomiting. These effects are generally mild and transient, but severe reactions should be reported to a healthcare provider immediately.

Fetcroja should be administered under medical supervision due to its potent nature. Patients with a history of allergic reactions to beta-lactam antibiotics should use it with caution. Regular monitoring of liver and kidney function is recommended during treatment.

Fetcroja may interact with other antibiotics, particularly those that affect renal function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided during treatment to minimize the risk of adverse effects.